Expansion Therapeutics hauls in $55.3 mln Series A
San Diego and Jupiter, Florida-based Expansion Therapeutics, a developer of ribonucleic acid targeted small molecule medicines, has secured $55.3 million in Series A financing. The lead investors were 5AM Ventures, Kleiner Perkins, Novartis Venture Fund and Sanofi Ventures. Also, RA Capital Management and Alexandria Venture Investments participated in the round.
3 January 2018•1 min read
